Black Diamond Therapeutics (BDTX) Shares Outstanding (Weighted Average): 2019-2021
Historic Shares Outstanding (Weighted Average) for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2021 value amounting to $36.2 million.
- Black Diamond Therapeutics' Shares Outstanding (Weighted Average) rose 0.65% to $36.2 million in Q4 2021 from the same period last year, while for Sep 2021 it was $36.2 million, marking a year-over-year increase of 0.84%. This contributed to the annual value of $56.6 million for FY2024, which is 9.59% up from last year.
- Black Diamond Therapeutics' Shares Outstanding (Weighted Average) amounted to $36.2 million in Q4 2021, which was up 0.04% from $36.2 million recorded in Q3 2021.
- In the past 5 years, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) registered a high of $36.2 million during Q4 2021, and its lowest value of $32.6 million during Q3 2019.
- In the last 3 years, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) had a median value of $36.0 million in 2020 and averaged $35.4 million.
- Data for Black Diamond Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 10.29% (in 2020) over the last 5 years.
- Black Diamond Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $32.6 million in 2019, then grew by 10.29% to $36.0 million in 2020, then grew by 0.65% to $36.2 million in 2021.
- Its last three reported values are $36.2 million in Q4 2021, $36.2 million for Q3 2021, and $36.2 million during Q2 2021.